Literature DB >> 7617877

Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging.

W B Morrison1, M E Schweitzer, K L Wapner, P J Hecht, F H Gannon, W R Behm.   

Abstract

PURPOSE: To evaluate sensitivity, specificity, clinical utility, and cost-effectiveness of magnetic resonance (MR) imaging in the diagnosis of osteomyelitis of the foot in diabetics.
MATERIALS AND METHODS: MR studies of 62 feet (diabetics [n = 27], nondiabetics [n = 35]) in 59 patients were prospectively evaluated to detect the presence and extent of osteomyelitis. Biopsy (n = 41 feet) and clinical follow-up (n = 62 feet) were used to establish the diagnosis, select treatment, and determine outcome; sensitivity and specificity of MR imaging were calculated. A cost analysis was performed.
RESULTS: Sensitivity and specificity of MR imaging in the diagnosis of osteomyelitis were 82% and 80%, respectively, in diabetics and 89% and 94%, respectively, in nondiabetics. There was no recurrent infection at the surgical margin in 13 feet in which the area of limited resection had been delineated at MR imaging.
CONCLUSION: MR imaging shows good sensitivity and specificity for diagnosing osteomyelitis in diabetic feet, and it is competitively priced compared with other imaging modalities. Accurate delineation of extent allows limited surgical resection, making MR imaging clinically useful and cost-effective.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617877     DOI: 10.1148/radiology.196.2.7617877

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

2.  Performance of a rapid two-sequence screening protocol for osteomyelitis of the foot.

Authors:  Adam D Singer; Monica Umpierrez; Aparna Kakarala; Marcos C Schechter; Michael Maceroli; Gulshan B Sharma; Ravi R Rajani
Journal:  Skeletal Radiol       Date:  2020-01-14       Impact factor: 2.199

Review 3.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

4.  Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis.

Authors:  U Rozzanigo; A Tagliani; E Vittorini; R Pacchioni; L Renzi Brivio; R Caudana
Journal:  Radiol Med       Date:  2008-10-25       Impact factor: 3.469

5.  [Diagnosis of chronic osteitis of the bones in the extremities. Relative value of F-18 FDG-PET].

Authors:  M Goebel; F Rosa; K Tatsch; A Grillhoesl; G O Hofmann; M H Kirschner
Journal:  Unfallchirurg       Date:  2007-10       Impact factor: 1.000

6.  Comparison of sequences for depicting bone marrow alterations in osteomyelitis applied in a low field strength magnetic resonance imaging system.

Authors:  H Bonél; T Helmberger; H C Geiss; M Steinborn; M M Ritter; M Reiser
Journal:  MAGMA       Date:  1998-11       Impact factor: 2.310

7.  Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot.

Authors:  Asad Nawaz; Drew A Torigian; Evan S Siegelman; Sandip Basu; Timothy Chryssikos; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2009-10-09       Impact factor: 3.488

8.  Diagnostic Accuracy and Surgical Utility of MRI in Complicated Diabetic Foot.

Authors:  Mayank Mahendra; Rahul Singh
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 9.  Management and prevention of diabetic foot ulcers and infections: a health economic review.

Authors:  Ivy Chow; Elkin V Lemos; Thomas R Einarson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Indexing severity of diabetic foot infection with 99mTc-WBC SPECT/CT hybrid imaging.

Authors:  William A Erdman; Ji Buethe; Rafia Bhore; Hans K Ghayee; Chiarra Thompson; Param Maewal; Jon Anderson; Steve Klemow; Orhan K Oz
Journal:  Diabetes Care       Date:  2012-06-20       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.